Literature DB >> 36266570

Low-intensity pulsed ultrasound partially reversed the deleterious effects of a severe spinal cord injury-induced bone loss and osteoporotic fracture healing in paraplegic rats.

Ariane Zamarioli1, Mariana M Butezloff2, João P B Ximenez3, José B Volpon2.   

Abstract

PURPOSE: To evaluate the effects of low-intensity pulsed ultrasound (LIPUS) on the quality of femoral fracture callus formation in rats with severe osteoporosis secondary to spinal cord injury (SCI).
METHODS: Forty-five male rats were equally divided into three groups: the Sham group underwent sham surgery for SCI followed by surgery for femoral fracture on day ten post-spine surgery; the SCI group sustained a complete transection of the spinal cord and a femoral fracture ten days post-SCI; and the SCI group treated with ultrasound (SCI + US), which also sustained a femoral fracture on day ten post-SCI, concomitant with daily application of LIPUS at the fracture site.
RESULTS: At the non-fractured tibias, LIPUS counteracted the SCI-induced bone loss by normalizing the osteoblastic-related gene expression, decreasing resorptive area, increasing trabecular area, and decreasing RANK and RANK-L-positive areas, which resulted in higher cortical volume and stronger tibias. Likewise, LIPUS was effective at restoring bone fracture healing in SCI rats; by promoting endochondral ossification, increasing collagen deposition and OPG-positive-area, decreasing resorptive area, which led to higher density and improved microarchitecture, ultimately resulting in stronger fracture callus.
CONCLUSION: At the tibias, LIPUS counteracted the SCI-induced bone loss effects by simultaneously increasing bone formation and decreasing bone resorption. We also evidenced the osteogenic effects of LIPUS at partially restoring the endochondral ossification during callus formation, leading to a newly formed tissue with improved microarchitecture and mechanical integrity. Therefore, LIPUS may be an efficient and non-invasive approach to prevent bone loss and osteoporotic fracture in SCI individuals.
© 2022. The Author(s), under exclusive licence to International Spinal Cord Society.

Entities:  

Year:  2022        PMID: 36266570     DOI: 10.1038/s41393-022-00863-1

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.473


  7 in total

1.  Low-intensity pulsed ultrasound (LIPUS) for stimulation of bone healing - A narrative review.

Authors:  Andrew Harrison; Volker Alt
Journal:  Injury       Date:  2021-05-12       Impact factor: 2.586

Review 2.  Healing of fracture nonunions treated with low-intensity pulsed ultrasound (LIPUS): A systematic review and meta-analysis.

Authors:  Ross Leighton; J Tracy Watson; Peter Giannoudis; Costas Papakostidis; Andrew Harrison; R Grant Steen
Journal:  Injury       Date:  2017-05-15       Impact factor: 2.586

3.  The stimulation of bone growth by ultrasound.

Authors:  L R Duarte
Journal:  Arch Orthop Trauma Surg       Date:  1983

4.  Low-intensity pulsed ultrasound accelerated callus formation, angiogenesis and callus remodeling in osteoporotic fracture healing.

Authors:  Wing-Hoi Cheung; Simon Kwoon-Ho Chow; Ming-Hui Sun; Ling Qin; Kwok-Sui Leung
Journal:  Ultrasound Med Biol       Date:  2011-02       Impact factor: 2.998

Review 5.  Effects of low-intensity pulsed ultrasound therapy on fracture healing: a systematic review and meta-analysis.

Authors:  Siamak Bashardoust Tajali; Pamela Houghton; Joy C MacDermid; Ruby Grewal
Journal:  Am J Phys Med Rehabil       Date:  2012-04       Impact factor: 2.159

Review 6.  Osteoporosis after spinal cord injury: aetiology, effects and therapeutic approaches.

Authors:  Shima Abdelrahman; Alex Ireland; Elizabeth M Winter; Mariel Purcell; Sylvie Coupaud
Journal:  J Musculoskelet Neuronal Interact       Date:  2021-03-01       Impact factor: 2.041

Review 7.  Coronary heart disease in individuals with spinal cord injury: assessment of risk factors.

Authors:  W A Bauman; A M Spungen
Journal:  Spinal Cord       Date:  2008-01-08       Impact factor: 2.772

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.